Magnesium Oxide and Vitamin C in Migraine

Phase 2

Recruiting

• Conditions: Condition 1: Common Migraines. Condition 2: Classic Migraine.; Migraine without aura; Migraine with aura; G43.0; G43.1

• Registration Number: IRCT20201221049787N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

According to ICHD-3 standards, the diagnosis of migraine should be made by a neurologist and they should be diagnosed with migraine at least one year before the visit
Diagnosis of moderate to severe migraine (which is the number of headache attacks 2-15 times a month or attacks with less intensity and duration that cause the person to be unable to perform daily tasks

Exclusion Criteria

Fever or evidence of infection
Simultaneous onset of other headaches such as tension headaches, sinusitis, or substance abuse headaches
People with active peptic ulcer and severe gastrointestinal disorders, especially chronic diarrhea
History of kidney failure
History of diabetes
history of major depression
History of asthma and heart disease (conduction block and heart failure)
Daily use of painkillers
Pregnancy or pregnancy intent
Having chronic diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of migraine headaches on daily activities. Timepoint: At the beginning of the study and after eight weeks of medication. Method of measurement: MSQ questionnaire.;Depression score in Beck questionnaire. Timepoint: At the beginning of the study and after eight weeks of medication. Method of measurement: Beck Depression Inventory.